Navigation Links
Nautilus Neurosciences and Tribute Pharmaceuticals Announce Exclusive Canadian License for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine
Date:11/16/2010

BEDMINSTER, N.J., and MILTON, Canada, Nov. 16, 2010 /PRNewswire/ -- Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, and Tribute Pharmaceuticals, a privately-held Canadian specialty pharmaceutical company, announced today their exclusive license agreement for the commercialization of CAMBIA™ (diclofenac potassium for oral solution) in Canada.  CAMBIA™ is approved in the United States for the acute treatment of migraine with or without aura and was launched in the United States in June 2010.  

"Canada is an important pharmaceutical market and opportunity for CAMBIA," said James Fares, Chairman and CEO, of Nautilus Neurosciences. "The management team at Tribute Pharmaceuticals has a wealth of experience in developing, launching and successfully commercializing new products in Canada.  This partnership along with recent developments in the US has significantly enhanced our ability to market CAMBIA™ to the broader North American market and reach more people suffering from acute migraine headaches.  We look forward to completing the expansion of our efforts through the addition of a partner for the family practice market in the United States in 2011."

Rob Harris, President & CEO of Tribute Pharmaceuticals points out that, "According to IMS, the prescription drug market in Canada for treating migraine headaches is valued at approximately one hundred and fifty million dollars."  Many Canadians who suffer from migraines are dissatisfied with their current medication and hope for a better treatment.  "Tribute Pharmaceuticals is very excited about the potential for CAMBIA™ in Canada and we look forward to building a strong partnership with Nautilus Neurosciences."

According to a survey published in the Journal of the American Board of Family Medicine, many people still hope to find a better treatment for their migraines, with more than a quarter dissatisfied w
'/>"/>

SOURCE Nautilus Neurosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
2. US WorldMeds Acquires Solstice Neurosciences
3. Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimers Disease
4. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
5. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
6. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
7. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
8. Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
9. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Calif. and NEW YORK , May 26, ... VAR ) and Flatiron Health today announced ... generation of cloud-based, electronic health record (EHR), data analytics ... the world. Together, the companies will build upon their ... medical oncology, radiation oncology and data analytics product suite. ...
(Date:5/26/2015)... Boehringer Ingelheim today announced that the ... STIOLTO™ RESPIMAT ® (tiotropium bromide and olodaterol) ... long-term, once-daily maintenance treatment of airflow obstruction in ... chronic bronchitis and/or emphysema. STIOLTO RESPIMAT is not ... COPD. COPD, which includes chronic bronchitis ...
(Date:5/26/2015)... N.Y. , May 26, 2015  Northstar ... the company has solidified a deal with Mr. ... out the company,s anti-snoring product, SNORenz to brick ... rollout will include a cross section of about ... in several states providing valuable statistics during the ...
Breaking Medicine Technology:Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 2Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 3Varian Medical Systems and Flatiron Health to Develop Next Generation of Cloud-based Oncology Software 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 2Northstar announces in-store rollout deal with national distribution group reaching more than 35,000 stores nationwide 3
... CLEVELAND, Dec. 1, 2011  NDI, a leading venture capital ... office, a third major location in addition to its ... The Minneapolis office will be run by medical device ... for Market Development. (Photo: ...
... Company (NYSE: LLY ) has been named one of ... partnership with FORTUNE and the RBL Group. Lilly ranked 16th on ... The survey is one of the most comprehensive studies ... Companies first complete an extensive survey, and senior executives from ...
Cached Medicine Technology:NDI Brings on Industry Veteran Mark Stultz to Head Up New Minneapolis Office 2Eli Lilly and Company Named a Top Global Company for Leaders 2
(Date:5/26/2015)... CIO Review has chosen SIGNiX for ... Sciences Technology Solution Providers. The positioning is based on an ... is applicable across the entire security spectrum of transactions within ... , “SIGNiX has been on our radar for some ... Sciences Technology space, and we are happy to showcase them ...
(Date:5/26/2015)... May 26, 2015 National Prevention Week ... year. It is supported by the Substance Abuse ... raising public awareness of, and action about, substance abuse ... organizations and coalitions are encouraged to join in promoting ... and related issues, and in building community partnerships. , ...
(Date:5/26/2015)... Scientists at the University of Pennsylvania believe ... mesothelioma patients benefit from immunotherapy; surgery may be the ... the new research. Click here to read it ... surgery and pulmonology theorized that, because large mesothelioma tumors ... immunotherapy drugs might work better if the tumor size ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 The best ... exercise may already be in your pocket. That’s because ... updated its LFconnect mobile app to sync with the ... Google Fit and Samsung S-Health – automatically transmitting data ... update, available now for download, empowers the millions of ...
(Date:5/26/2015)... May 26, 2015 General Networks ... MarkLogic Corporation. The alliance ensures joint customers will ... and General Networks’ expertise in building enterprise content ... MarkLogic will help customers integrate, manage and operationalize ... business processes. , “Our customers are seeking tools ...
Breaking Medicine News(10 mins):Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 3Health News:General Networks Corporation Announces Alliance with MarkLogic 2
... to raise awareness of the National Marrow Donor Program , ... ... Marrow Donor Program® (NMDP) and Preston Kelly, an independent agency in ... to increase awareness of the importance of joining the Be The ...
... EHRtv on EHR implementation and the state of Healtcare IT in ... ... 24, 2009 -- EHRtv.com, the newly launched website for Comprehensive Video ... interview Former Representative Richard Gephardt during the Recent HIMSS09 Health IT ...
... Khanna institute of Lasik gives back to the community and helps ... ... Village, CA (PRWEB) April 24, 2009 -- Oaks Christian is an ... village. Recently, The Khanna Institute supported their efforts and ...
... in the Lungs , A group led by Dr. ... as a mediator of lung fibrosis. They present their data in ... . , Scar tissue, or fibrosis, can accumulate in ... lung disease, respiratory failure, and eventually death. An increase in ...
... World Malaria Day Events Held in Nairobi , ... Washington LAUSANNE, Switzerland, ... on 4/25, ,Counting Malaria Out, Vestergaard Frandsen is stepping up ... a new version that is effective against insecticide resistant mosquitoes. Malaria ...
... might be replicated for heart disease, scientists say, , , THURSDAY, ... patient,s own skin cells to grow tissue-engineered shunts for dialysis ... The problem right now is that about half of all ... via a plastic tube that creates a shunt -- a ...
Cached Medicine News:Health News:Be The MatchSM Brand Campaign Launches 2Health News:Be The MatchSM Brand Campaign Launches 3Health News:Representative Richard Gephardt Sits Down With EHRtv.com 2Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Tips from the American Journal of Pathology 2Health News:Tips from the American Journal of Pathology 3Health News:Tips from the American Journal of Pathology 4Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 2Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 2Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 4
... The ABI PRISM 310 Genetic Analyzer ... for a wide range of sequencing and ... for academic and forensic labs who incorporate ... Genetic Analyzer -- the ideal alternative to ...
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: